Searchable abstracts of presentations at key conferences in endocrinology

ea0028p293 | Reproduction | SFEBES2012

Prevalence of modifiable risk factors among a clinic-based cohort of secondary hypogonadal men

Mclorinan Joanna , Overend Louise , Mohamed Yunus Ajmal , Mason Ryan , McNulty Steven , Furlong Niall , Srinivas-Shankar Upendram

Background: Male hypogonadism is commonly caused by hypothalamo-pituitary testicular disease. The effect of modifiable risk factors (obesity, alcohol, smoking, prescribed medications and recreational drugs) on secondary hypogonadism in a clinic-based cohort is unclear. The aim of this study was to ascertain the prevalence and effects of modifiable risk factors on secondary hypogonadism.Method: This was a retrospective, cross-sectional observational study...

ea0028p327 | Steroids | SFEBES2012

Medroxyprogesterone acetate-induced Adrenal Insufficiency

Overend Louise , McLorinan Joanna , Mason Ryan , Yunus Ajmal , Srinivas-Shankar Upendram

Case History: We report the case history of a 64-year-old woman who was admitted to hospital for evaluation of unsteadiness associated with postural hypotension. There was no history of headache, visual blurring, weight loss, diarrhoea or steroid treatment. She was taking high dose medroxyprogesterone acetate (MPA) 100 mg three times per day for 5 years following diagnosis of complex hyperplasia on endometrial biopsy for postmenopausal bleeding. Her past history included ischa...

ea0027oc4.1 | Oral Communications 4 | BSPED2011

Ethnicity rather than deprivation impacts on diabetes control and use of treatment regimen

Thompson Rebecca , Agostini Kirsty , Luscombe Jennifer , Potts Louise , Viner Russell , Hindmarsh Peter

Introduction: Delivering an equitable service is one component defining a quality service. Various factors impact on diabetes control including health beliefs and socioeconomic pressures. To determine the role played by ethnicity and/or deprivation we audited access to insulin treatment regimens and overall diabetes control in our clinic population of children and young people with type 1 diabetes mellitus (CYPT1DM).Methods: Three hundred and twenty-five...

ea0027p24 | (1) | BSPED2011

A case of familial isolated hypogonadotrophic hypogonadism due to FGFR1 G687R mutation

Tziaferi Vaitsa , Spoudeas Helen , McCabe Mark , Gregory Louise , Dattani Mehul T

Introduction: Hypogonadotrophic hypogonadism (HH) is a genetically heterogeneous disorder. A number of genes have been implicated in its pathogenesis but, to date, in most cases, the cause remains genetically unknown.Case: A 14-year old male with delayed puberty (G1P2A3, testes two males) and family history of HH was diagnosed with HH following anterior pituitary assessment and an overnight gonadotrophin profile. His baseline gonadotrophins were low (LH,...

ea0027p52 | (1) | BSPED2011

Educating children in continuous subcutaneous insulin infusion (CSII) therapy; are we improving diabetes control?

Lee Alice , Campbell Judith , Marshall Marie , Ainsworth Sue , Salisbury Louise , Bone Mark , Doughty Ian , Ehtisham Sarah

Background: Continuous subcutaneous insulin infusion (CSII) is proving superior in reducing HbA1c compared to multiple daily injections (MDI) in both the adult and paediatric populations. This study aims to compare the two methods, and evaluate the importance of education when starting insulin pump therapy in children.Design: Patients who attended a ‘pump school’ provided by the Royal Manchester Children’s Hospital between January 2010 and...

ea0025p99 | Clinical biochemistry | SFEBES2011

Metastatic insulinoma in a patient with type 2 diabetes mellitus: case report

Abbasakoor Noormuhammad , Healy Marie-Louise , O'Shea Donal , Maguire Donal , Muldoon Cian , Sheahan Kieran , O'Toole Dermot

Introduction: Insulinoma is a tumour, derived from the beta cells of the pancreas. The incidence in the general population is 4 cases per million a year. 80 to 90% of insulinomas are benign and <10% are malignant.Case presentation: A 67-year-old lady was admitted via the emergency department after being found unresponsive at home. She was found to be hypoglycaemic and responded to i.v. dextrose. She was diagnosed with type 2 diabetes mellitus a year ...

ea0025p301 | Steroids | SFEBES2011

An atypical case of familial glucocorticoid deficiency without pigmentation caused by coexistent homozygous mutations in MC2R (T152K) and MC1R (R160W)

Hughes Claire , Turan Serap , Atay Zeynep , Guran Tulay , Bereket Abdullah , Clark Adrian , Metherell Louise

Familial glucocorticoid deficiency (FGD) is a rare autosomal recessive disorder characterised by unresponsiveness to ACTH and isolated cortisol deficiency. FGD is caused by mutations in genes encoding the ACTH receptor (melanocortin 2 receptor (MC2R)), its accessory protein (MRAP) or the steroidogenic acute regulatory protein (StAR). One significant feature is generalized skin hyperpigmentation which is thought to be due to elevated ACTH acting on the melanocortin 1 receptor (...

ea0023p28 | (1) | BSPED2009

46 XY girls – the importance of careful newborn examination

Sharp Tim , Fraser Nia , Shenoy Manoj , Randell Tabitha , Denvir Louise , Williams Alun

Introduction: Disorders of sexual differentiation (DSD) are uncommon and pose many challenges to families affected and clinicians. The genotypic 46XY male with female phenotype form an interesting group with diverse presentation. We studied all such children attending our multidisciplinary DSD clinic. Only in a minority of these children did newborn examination raise the possibility of DSD. Delays in identifying these abnormalities can cause significant psychological difficult...

ea0021p214 | Endocrine tumours and neoplasia | SFEBES2009

Mutations of the transcription factor, GATA3, in oestrogen receptor positive breast cancers

Gaynor Katherine , Grigorieva Irina , Esapa Chris , Head Rosie , Christie Paul , Nesbit Andrew , Jones Louise , Thakker Rajesh

Mutations of the transcription factor GATA3, which is important for maintaining human breast luminal epithelial cell differentiation and quiescence, have been reported in 17 oestrogen receptor (ER) positive breast cancers, although the functional effects of these mutations have not been studied. We therefore investigated 56 ER-positive breast cancers for GATA3 mutations. The tumours were macrodissected, and immunohistochemistry for GATA3 revealed a strong correlation between E...

ea0021p286 | Pituitary | SFEBES2009

Oral and transdermal oestrogen treatments have differing effects on GH sensitivity in hypopituitary women receiving GH replacement

Tanna Amit , Madula Rajiv , Sandhu Harinderjeet , Powrie Jake , Thomas Stephen , Brackenridge Anna , Breen Louise , Carroll Paul

Background: The route of oestrogen replacement has an influence on GH sensitivity in hypopituitary women, although the practical relevance of this effect remains unclear.Objectives: To compare the effects of oral and transdermal oestrogen replacement on GH requirement in adult females with hypopituitarism receiving GH replacement.Methods: This cross-sectional, observational study included 69 GH-deficient women each receiving a stab...